日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Electroacupuncture for Managing Chemotherapy-Induced Gastrointestinal Symptom Clusters in Patients With Breast Cancer: Study Protocol for a Randomized Controlled Trial

电针疗法治疗乳腺癌患者化疗引起的胃肠道症状群：一项随机对照试验的研究方案

期刊:
影响因子:
doi:10.1002/hcs2.70056
Tao, Xinlong; Liu, Zhen; Wang, Miaozhou; Ren, Dengfeng; Zhao, Fuxing; Wang, Hongbin; Yang, Guowang; Zhang, Ganlin; Li, Zitao; Liu, Zhilin; Huang, Shifen; Chen, Yongzhi; Da, Mengting; Ma, Xiaoyan; Liang, Hongxia; Li, Yongxin; Ye, Yinyin; Zheng, Yonghui; Liang, Xiao; Shen, Guoshuang; Bai, Xiaorong; Zhao, Jiuda
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Novel CDK2/4/6 inhibitor culmerciclib (TQB3616) plus fulvestrant in previously treated, HR-positive, HER2-negative advanced breast cancer: a randomized, double-blind, phase 3 trial

新型 CDK2/4/6 抑制剂 culmerciclib (TQB3616) 联合氟维司群治疗既往接受过治疗的 HR 阳性、HER2 阴性晚期乳腺癌：一项随机、双盲、3 期试验

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02475-6
Yin, Yongmei; Zhang, Qingyuan; Sun, Tao; Hao, Chunfang; Wang, Zhihong; Yang, Jin; Wang, Yongsheng; Shi, Yanxia; Sun, Jing; Ouyang, Quchang; Su, Haichuan; Wu, Jinsheng; Gan, Lu; Han, Meng; Gao, Liming; Wang, Xiaojia; Zhao, Bing; Li, Hui; Zhao, Jiuda; Yang, Hongwei; Ning, Fangling; Tian, Fuguo; Zhang, Juliang; Sun, Hongmei; Niu, Zhaofeng; Zong, Hong; Zang, Aimin; Wang, Xinshuai; Qian, Xinyu; Wu, Shikai; Nie, Jianyun; He, Lijia; Cheng, Ying; Hao, Yanrong; Zhai, Yi; Li, Huiping; Wang, Jingfen; Wei, Shihong; Li, Man; Liu, Yunjiang; Guo, Hongqiang; Hu, Qun; Liu, Lina; Han, Xinghua; Luo, Ruizhen; Ni, Mingli; Tang, Xianjun; Zhai, Zhenhua; Ding, Meiqian; Wang, Haibo; Shen, Peng; Wang, Xian; Liu, Lian; Chen, Wenyan; Liu, Gang; Cai, Zhengwen; Jiang, Zefei
肿瘤
HER2
肿瘤免疫
乳腺癌
CDK2
发表日期：2025
文献求助 收藏

Neoadjuvant apatinib addition to sintilimab and carboplatin-taxane based chemotherapy in patients with early triple-negative breast cancer: the phase 2 NeoSAC trial

在早期三阴性乳腺癌患者中，新辅助阿帕替尼联合信迪利单抗和卡铂-紫杉烷类化疗：NeoSAC II期试验

期刊:Signal Transduction and Targeted Therapy
影响因子:52.7
doi:10.1038/s41392-025-02137-7
Shen, Guoshuang; Liu, Zhilin; Wang, Miaozhou; Zhao, Yi; Liu, Xinlan; Hou, Yujin; Ma, Wenbiao; Han, Jingqi; Zhou, Xiaofeng; Ren, Dengfeng; Zhao, Fuxing; Li, Zitao; Huang, Shifen; Chen, Yongzhi; He, Yingjian; Liu, Yan; Zhu, Zijun; Li, Yongxin; Li, Jinming; Da, Mengting; Mo, Hongnan; Du, Feng; Cui, Liang; Bai, Jing; Liu, Zhen; Ma, Fei; Zhao, Jiuda
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

GGT and GSH-triggered nanoplatform for efficient gambogic acid delivery and tumor penetration in triple-negative breast cancer

GGT和GSH触发的纳米平台可有效递送藤黄酸并促进其在三阴性乳腺癌中的肿瘤渗透

期刊:Materials Today Bio
影响因子:10.2
doi:10.1016/j.mtbio.2025.102030
Li, Su; Wang, Qinghua; Su, Chen; Jia, Zhen; Shen, Guoshuang; Da, Mengting; Yang, Rui; Zhao, Jiuda; Chen, Daozhen
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Disproportionality analysis of interstitial lung disease associated with novel antineoplastic agents during breast cancer treatment: a pharmacovigilance study

乳腺癌治疗期间新型抗肿瘤药物相关间质性肺病比例失调分析：一项药物警戒研究

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103160
Zhu, Zijun; Li, Yongxin; Zhu, Chaoyong; Dong, Qiuxia; Zhang, Yixiao; Liu, Zhilin; Ren, Dengfeng; Zhao, Fuxing; Zhao, Jiuda
特发性肺纤维化
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

Response to "complexity of interstitial lung disease disproportionality signal analysis in pharmacovigilance databases"

对“药物警戒数据库中间质性肺病不成比例信号分析的复杂性”的回应

期刊:EClinicalMedicine
影响因子:10
doi:10.1016/j.eclinm.2025.103451
Zhu, Zijun; Li, Yongxin; Zhao, Jiuda
信号转导
特发性肺纤维化
发表日期：2025
文献求助 收藏

Real-world effectiveness of goserelin 10.8-mg compared to goserelin 3.6-mg in premenopausal and perimenopausal Chinese patients with hormone receptor positive breast cancer: a cohort study

戈舍瑞林10.8 mg与戈舍瑞林3.6 mg在绝经前和围绝经期中国激素受体阳性乳腺癌患者中的真实世界疗效比较：一项队列研究

期刊:Journal of the National Cancer Center
影响因子:9.4
doi:10.1016/j.jncc.2025.02.006
Wang, Yongsheng; Wang, Xi; Wu, Jiong; Liu, Hong; Zhao, Jiuda; Huang, Jian; Liu, Jianxia; Gong, Youling; Wang, Hao; Yang, Huaqing; Zou, Guorong; Ouyang, Quchang; Jiang, Guoqin; Liu, Huijuan; Ni, Sujie; Xu, Binghe; Yu, Jinming
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2025
文献求助 收藏

Prevalence of six respiratory pathogens among children in Chengdu, China: a multiplex PCR-based detection study

中国成都市儿童六种呼吸道病原体流行情况：一项基于多重PCR的检测研究

期刊:Frontiers in Cellular and Infection Microbiology
影响因子:4.8
doi:10.3389/fcimb.2025.1690701
Liu, Chenggui; Li, Jiuda; Deng, Yao; Wang, Qin; Wang, Xuemei; Yang, Shuzhe; He, Weijun; Liao, Zhiyong
微生物学
发表日期：2025
文献求助 收藏

Pyrotinib versus pertuzumab with trastuzumab and taxane in HER2-positive metastatic breast cancer: a Chinese multicenter real-world study

在HER2阳性转移性乳腺癌中，吡咯替尼与帕妥珠单抗联合曲妥珠单抗和紫杉烷类药物的疗效比较：一项中国多中心真实世界研究

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf277
Liu, Binliang; Yi, Zongbi; Tian, Can; Deng, Jian; Feng, Ronghua; Hu, Zhe-Yu; Xie, Ning; Li, Yongxin; Zhao, Jiuda; Wu, Tao; Ouyang, Quchang
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

The immune-related gene CD5 is a prognostic biomarker associated with the tumor microenvironment of breast cancer

免疫相关基因CD5是与乳腺癌肿瘤微环境相关的预后生物标志物。

期刊:Discover Oncology
影响因子:2.9
doi:10.1007/s12672-024-01616-7
Zhao, Yi; Zhang, Hengheng; Wang, Wenwen; Shen, Guoshuang; Wang, Miaozhou; Liu, Zhen; Zhao, Jiuda; Li, Jinming
肿瘤
CD5
肿瘤免疫
乳腺癌
肿瘤微环境
免疫/内分泌
发表日期：2025
文献求助 收藏